Literature DB >> 19116262

Metabolism of vitamin d2 to 17,20,24-trihydroxyvitamin d2 by cytochrome p450scc (CYP11A1).

Minh N Nguyen1, Andrzej Slominski, Wei Li, Yun Rui Ng, Robert C Tuckey.   

Abstract

As well as catalyzing the conversion of cholesterol to pregnenolone for steroid synthesis, cytochrome P450scc (P450scc) can also metabolize vitamins D2 (D2) and D3 (D3). Two products of D2 metabolism by P450scc, 20-hydroxyvitamin D2 and 17,20-dihydroxyvitamin D2, have been identified and shown to exert biological activity on cultured keratinocytes. The aim of this study was to fully characterize the metabolism of D2 by P450scc, including identifying additional products and determining the kinetics of D2 metabolism. Two new products were isolated by reverse-phase high-performance liquid chromatography: a dihydroxy metabolite with a hydroxyl group at C20 plus another unidentified position, and a trihydroxy metabolite identified by NMR as 17,20,24-trihydroxyvitamin D2. Kinetics of D2 metabolism was determined with substrate solubilized by 2-hydroxypropyl-beta-cyclodextrin or incorporated into phospholipid vesicles. In 2-hydroxypropyl-beta-cyclodextrin, D2 was hydroxylated at C20 with a k(cat)/K(m) 5-fold lower than that for cholesterol metabolism. 20-Hydroxyvitamin D2 was hydroxylated with a similar k(cat)/K(m) to D2, whereas 17,20-dihydroxyvitamin D2 was hydroxylated with a lower k(cat)/K(m) than that for D2 in 2-hydroxypropyl-beta-cyclodextrin. In vesicles, D2 displayed a high K(m) relative to that for cholesterol, but hydroxylation resulted in products that could be further hydroxylated with relatively low K(m) values. We conclude that P450scc catalyzes three sequential hydroxylations of D2 producing 20-hydroxyvitamin D2, 17,20-dihydroxyvitamin D2, and 17,20,24-trihydroxyvitamin D2, which dissociate from the active site of P450scc and accumulate in the reaction mixture. D2 metabolism occurs with lower efficiency (k(cat)/K(m)) than that observed for both cholesterol and D3 metabolism by P450scc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116262      PMCID: PMC2659330          DOI: 10.1124/dmd.108.025619

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  29 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  An alternative pathway of vitamin D metabolism. Cytochrome P450scc (CYP11A1)-mediated conversion to 20-hydroxyvitamin D2 and 17,20-dihydroxyvitamin D2.

Authors:  Andrzej Slominski; Igor Semak; Jacobo Wortsman; Jordan Zjawiony; Wei Li; Blazej Zbytek; Robert C Tuckey
Journal:  FEBS J       Date:  2006-07       Impact factor: 5.542

3.  The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism.

Authors:  Andrzej Slominski; Igor Semak; Jordan Zjawiony; Jacobo Wortsman; Wei Li; Andre Szczesniewski; Robert C Tuckey
Journal:  FEBS J       Date:  2005-08       Impact factor: 5.542

Review 4.  Progesterone synthesis by the human placenta.

Authors:  Robert C Tuckey
Journal:  Placenta       Date:  2005-04       Impact factor: 3.481

5.  Enzymatic metabolism of ergosterol by cytochrome p450scc to biologically active 17alpha,24-dihydroxyergosterol.

Authors:  Andrzej Slominski; Igor Semak; Jordan Zjawiony; Jacobo Wortsman; Michael N Gandy; Jinghu Li; Blazej Zbytek; Wei Li; Robert C Tuckey
Journal:  Chem Biol       Date:  2005-08

6.  Vitamin D2 is much less effective than vitamin D3 in humans.

Authors:  Laura A G Armas; Bruce W Hollis; Robert P Heaney
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

7.  Incorporation of vitamin D3-derivatives in liposomes of different lipid types.

Authors:  K Merz; B Sternberg
Journal:  J Drug Target       Date:  1994       Impact factor: 5.121

8.  Properties of ferredoxin reductase and ferredoxin from the bovine corpus luteum.

Authors:  R C Tuckey; P M Stevenson
Journal:  Int J Biochem       Date:  1984

9.  Purification and analysis of phospholipids in the inner mitochondrial membrane fraction of bovine corpus luteum, and properties of cytochrome P-450scc incorporated into vesicles prepared from these phospholipids.

Authors:  R C Tuckey; P M Stevenson
Journal:  Eur J Biochem       Date:  1985-04-15

Review 10.  Enzymes involved in the activation and inactivation of vitamin D.

Authors:  David E Prosser; Glenville Jones
Journal:  Trends Biochem Sci       Date:  2004-12       Impact factor: 13.807

View more
  33 in total

1.  Metabolism of 20-hydroxyvitamin D3 and 20,23-dihydroxyvitamin D3 by rat and human CYP24A1.

Authors:  Elaine W Tieu; Wei Li; Jianjun Chen; Tae-Kang Kim; Dejian Ma; Andrzej T Slominski; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2015-02-26       Impact factor: 4.292

Review 2.  New vitamin D analogs as potential therapeutics in melanoma.

Authors:  Paulina Szyszka; Michal A Zmijewski; Andrzej T Slominski
Journal:  Expert Rev Anticancer Ther       Date:  2012-05       Impact factor: 4.512

Review 3.  The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Wei Li; Ae-Kyung Yi; Arnold Postlethwaite; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2013-10-28       Impact factor: 4.292

Review 4.  Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Wojciech Jóźwicki; Anton M Jetten; Rebecca S Mason; Robert C Tuckey; Craig A Elmets
Journal:  Lab Invest       Date:  2017-02-20       Impact factor: 5.662

5.  Cytochrome P450scc-dependent metabolism of 7-dehydrocholesterol in placenta and epidermal keratinocytes.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Jianjun Chen; Minh N Nguyen; Wei Li; Charles R Yates; Trevor Sweatman; Zorica Janjetovic; Robert C Tuckey
Journal:  Int J Biochem Cell Biol       Date:  2012-08-02       Impact factor: 5.085

6.  Production of 22-hydroxy metabolites of vitamin d3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells.

Authors:  Robert C Tuckey; Wei Li; Haleem Z Shehabi; Zorica Janjetovic; Minh N Nguyen; Tae-Kang Kim; Jianjun Chen; Danielle E Howell; Heather A E Benson; Trevor Sweatman; Donna M Baldisseri; Andrzej Slominski
Journal:  Drug Metab Dispos       Date:  2011-06-15       Impact factor: 3.922

7.  De novo synthesis of steroids and oxysterols in adipocytes.

Authors:  Jiehan Li; Edward Daly; Enrico Campioli; Martin Wabitsch; Vassilios Papadopoulos
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

8.  Novel vitamin D analogs as potential therapeutics: metabolism, toxicity profiling, and antiproliferative activity.

Authors:  Jianjun Chen; Jin Wang; Tae-Kang Kim; Elaine W Tieu; Edith K Y Tang; Zongtao Lin; Dianne Kovacic; Duane D Miller; Arnold Postlethwaite; Robert C Tuckey; Andrzej T Slominski; Wei Li
Journal:  Anticancer Res       Date:  2014-05       Impact factor: 2.480

Review 9.  Endogenously produced nonclassical vitamin D hydroxy-metabolites act as "biased" agonists on VDR and inverse agonists on RORα and RORγ.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Judith V Hobrath; Allen S W Oak; Edith K Y Tang; Elaine W Tieu; Wei Li; Robert C Tuckey; Anton M Jetten
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-28       Impact factor: 4.292

10.  Hydroxylation of CYP11A1-derived products of vitamin D3 metabolism by human and mouse CYP27B1.

Authors:  Edith K Y Tang; Jianjun Chen; Zorica Janjetovic; Elaine W Tieu; Andrzej T Slominski; Wei Li; Robert C Tuckey
Journal:  Drug Metab Dispos       Date:  2013-03-01       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.